Kringle Pharma (TSE:4884) Institutional Ownership: 0.27% (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4884 Kringle Pharma Inc TSE:4884
50 GF Score
Price 円362.00
GF Value 円483.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Kringle Pharma Institutional Ownership?

Kringle Pharma TSE:4884 +4.32% 50 Institutional Ownership is 0.27% as of Aug. 11, 2026. GuruFocus rates TSE:4884 with a GF Score™ of 50/100 and a GF Value™ of 円483.87 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kringle Pharma's institutional ownership is 0.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kringle Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kringle Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Kringle Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Kringle Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kringle Pharma Institutional Ownership Chart

Kringle Pharma Historical Data

The historical data trend for Kringle Pharma can be seen below:

2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2026-05-31 2026-06-30
Institutional Ownership 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.27 0.27
TSE:4884
50GF Score
Kringle Pharma Inc TSE:4884
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kringle Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.27% mean?
Kringle Pharma (TSE:4884) has a Institutional Ownership of 0.27% as of Aug. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Kringle Pharma and its competitors.
Is Kringle Pharma's Institutional Ownership too high?
Kringle Pharma's current Institutional Ownership is 0.27%. Overall, Kringle Pharma has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kringle Pharma's Institutional Ownership compare to VRTX and REGN?
Kringle Pharma's Institutional Ownership of 0.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Kringle Pharma and its competitors. Kringle Pharma's current Institutional Ownership is 0.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kringle Pharma stock overvalued right now?
Based on GuruFocus' analysis, Kringle Pharma (TSE:4884) is currently considered Modestly Undervalued. The stock's GF Value™ is 円483.87, compared to a current price of 円362.00 — trading 25.2% below its estimated fair value. The current Institutional Ownership is 0.27%. Kringle Pharma's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Kringle Pharma (TSE:4884), the current Institutional Ownership is 0.27% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kringle Pharma (TSE:4884) Overvalued in 2026?

Based on GuruFocus' analysis, Kringle Pharma stock appears to be undervalued. The current stock price of 円362.00 is trading 25.2% below its estimated GF Value™ of 円483.87. GuruFocus considers Kringle Pharma to be Modestly Undervalued.

Key valuation signals for TSE:4884:

  • Institutional Ownership: 0.27%
  • GF Value™: 円483.87 vs. price of 円362.00 (25.2% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the TSE:4884 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kringle Pharma Business Description

Address 7-7-15 Saito asagi, 207 Saito Bio-Incubator, Osaka Prefecture, Ibaraki, JPN, 567-0085
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases. The Company operates in a single segment, pharmaceutical development.
50GF Score

Get the complete analysis for TSE:4884

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円362.00
Price
円483.87
GF Value